These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12487756)

  • 21. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO; Agbedana EO; Kadiri S; Taylor GO
    Afr J Med Med Sci; 1999; 28(1-2):97-100. PubMed ID: 12953996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M; Taş S; Sarandöl E; Tokullugil HA
    Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome.
    Kasiske BL; Velosa JA; Halstenson CE; La Belle P; Langendörfer A; Keane WF
    Am J Kidney Dis; 1990 Jan; 15(1):8-15. PubMed ID: 2294737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M; Salamatullah Q; Ferdous Z; Hussain MA
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-lowering agents in proteinuric diseases.
    Appel GB; Appel AS
    Am J Nephrol; 1990; 10 Suppl 1():110-5. PubMed ID: 2256470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotic origin hyperlipidemia, relative reduction of vitamin E level and subsequent oxidative stress may promote atherosclerosis.
    Skrzep-Poloczek B; Tomasik A; Tarnawski R; Hyla-Klekot L; Dyduch A; Wojciechowska C; Wesolowski W; Kopieczna-Grzebieniak E; Zalejska-Fiolka J; Widera E
    Nephron; 2001 Sep; 89(1):68-72. PubMed ID: 11528235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome.
    D'Amico G; Gentile MG; Manna G; Fellin G; Ciceri R; Cofano F; Petrini C; Lavarda F; Perolini S; Porrini M
    Lancet; 1992 May; 339(8802):1131-4. PubMed ID: 1349366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The metabolism characteristics of blood lipids and the correlation analysis of blood lipids and related factors such as age in the middle-aged and elderly men].
    Wang HJ; Si QJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jan; 28(1):89-93. PubMed ID: 22493905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report.
    Torres-Duran PV; Ferreira-Hermosillo A; Juarez-Oropeza MA
    Lipids Health Dis; 2007 Nov; 6():33. PubMed ID: 18039384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
    Kalaiarasi P; Kaviarasan K; Pugalendi KV
    Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bifidobacteria supplementation: effects on plasma lipid profiles in dyslipidemic children.
    Guardamagna O; Amaretti A; Puddu PE; Raimondi S; Abello F; Cagliero P; Rossi M
    Nutrition; 2014; 30(7-8):831-6. PubMed ID: 24985000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can group medical clinics improve lipid management in diabetes?
    Crowley MJ; Melnyk SD; Ostroff JL; Fredrickson SK; Jeffreys AS; Coffman CJ; Edelman D
    Am J Med; 2014 Feb; 127(2):145-51. PubMed ID: 24462012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study.
    Schrott HG; Knapp H; Davila M; Shurzinske L; Black D
    Am Heart J; 2000 Aug; 140(2):249-52. PubMed ID: 10925339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pravastatin on serum lipids and apolipoproteins in hyperlipidemia of the nephrotic syndrome.
    Tokoo M; Oguchi H; Terashima M; Tokunaga S; Miyasaka M; Hora K; Higuchi M; Yoshie T; Furuta S
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):397-403. PubMed ID: 1635284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of bezafibrate on hyperlipidaemia in experimental nephrotic syndrome in rats.
    Williams AJ; Baker FE; Walls J
    J Pharm Pharmacol; 1985 Oct; 37(10):741-3. PubMed ID: 2867148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A; Erasmus RT; Anjorin SA
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of probucol on hyperlipidemia in patients with nephrotic syndrome.
    Iida H; Izumino K; Asaka M; Fujita M; Nishino A; Sasayama S
    Nephron; 1987; 47(4):280-3. PubMed ID: 3696330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: results from a randomized controlled feeding trial.
    Maki KC; Lawless AL; Kelley KM; Kaden VN; Geiger CJ; Dicklin MR
    J Clin Lipidol; 2015; 9(1):49-57. PubMed ID: 25670360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.